Skip to main content
. 2021 Jul 28;2:100042. doi: 10.1016/j.crphar.2021.100042

Fig. 2.

Fig. 2

PRISMA flow diagram for the systematic review of the role of AI/ML in drug repurposing and drug development for COVID-19.